Catalyst Wire Dossier Catalyst Wire Dossier

human-cl rhFVIII

recombinant factor VIII concentrate (human-cl rhFVIII) · Octapharma
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for human-cl rhFVIII, covering 2018-01-30 to 2019-12-03. Get the full timeline:

Most recent: Clinical Trial Update: Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A [Phase 3]

See pricing